Central Pacific Bank - Trust Division’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$99.4K Hold
510
0.01% 589
2026
Q1
$114K Hold
510
0.01% 566
2025
Q4
$123K Sell
510
-20
-4% -$5.12K 0.02% 534
2025
Q3
$145K Sell
530
-35
-6% -$9.56K 0.02% 513
2025
Q2
$146K Hold
565
0.02% 505
2025
Q1
$126K Buy
565
+50
+10% +$11.7K 0.02% 534
2024
Q4
$118K Hold
515
0.02% 547
2024
Q3
$126K Sell
515
-1,620
-76% -$362K 0.02% 538
2024
Q2
$409K Hold
2,135
0.05% 364
2024
Q1
$404K Buy
+2,135
New +$391K 0.05% 391

Other funds holding RMD

Central Pacific Bank - Trust Division's RMD Position: Q2 2026 in Review

Central Pacific Bank - Trust Division held its ResMed (RMD) position steady in Q2 2026 at 510 shares worth $99.4K. The position accounts for 0.01% of the portfolio, ranked #589.

Central Pacific Bank - Trust Division first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $409K in Q2 2024. 488 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Central Pacific Bank - Trust Division held 510 shares of ResMed worth $99.4K as of Q2 2026.
  • Central Pacific Bank - Trust Division left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.01% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #589 holding.
  • Central Pacific Bank - Trust Division first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
  • Central Pacific Bank - Trust Division's ResMed position peaked at $409K in Q2 2024.
  • 488 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.